Viridian Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Viridian Therapeutics using advanced sorting and filters.
Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Sep 2024 | 2024-11-12 | $-1.15 | $-1.05 | -9.52 % |
Jun 2024 | 2024-08-08 | $-1.02 | $-0.89 | -14.6 % |
Mar 2024 | 2024-05-08 | $-0.79 | $-1.10 | 28.2 % |
Dec 2023 | 2024-02-27 | $-1.35 | $-1.00 | -35.0 % |
Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Sep 2024 | 2024-11-12 | $86.00K | $40.00K | 115.0 % |
Jun 2024 | 2024-08-08 | $72.00K | $90.00K | -20.0 % |
Mar 2024 | 2024-05-08 | $72.00K | $70.00K | 2.86 % |
Sep 2023 | 2023-11-13 | $72.00K | $110.00K | -34.5 % |
Viridian Therapeutics ({quoteSymbol}) does not have any upcoming earnings reports scheduled yet. The last reported earnings were for reported on November 12, 2024 for Q3.
Viridian Therapeutics ({quoteSymbol}) does not have any upcoming earnings reports scheduled yet. The last reported earnings were for reported on November 12, 2024 for Q3 and the Actual EPS was $-1.15, which missed the estimate of $-1.05.
Viridian Therapeutics ({quoteSymbol}) does not have any upcoming earnings reports scheduled yet. The last reported earnings were for reported on November 12, 2024 for Q3 and the Actual EPS was {{actualEPS}}, which beat the estimate of {{estEPS}}.
Browse earnings estimates, EPS, and revenue on all stocks.